ABX Guide | CME Program Library

Assessment Executive Assessment

Iyabode Akinsanya-Beysolow,
MD, MPH
Iyabode Akinsanya-Beysolow, MD, MPH

Medical Officer
Centers for Disease Control and Prevention
National Center for Immunization and Respiratory Disease
Atlanta, GA

This faculty member participated in the following program(s)
“Understanding and Implementing Hepatitis A, Influenza, Pneumococcus, and Rotavirus Vaccination in Infants and Young Children”

Andrew Angelino,
MD

Paul G. Auwaerter,
MD, MBA, FACP, FIDSA

Paul G. Auwaerter, MD, MBA, FIDSA

Sherrilyn and Ken Fisher Professor of Medicine
Clinical Director, Division of Infectious Diseases
John Hopkins University School of Medicine
Chief Medical Officer, Point of Care-Information Technology (POC-IT) Center
Johns Hopkins University School of Medicine

This faculty member participated in the following program(s)
“Optimizing Vaccination in Immunosuppressed Patients with Autoimmune and Inflammatory Disease”
“Current Evidence and Controversies in COVID-19: Discussion on Best Practices Amid Changing Evidence”
“Herpes Zoster Vaccination: What Clinicians Need to Know to Improve Vaccination Rates”
“Confronting Barriers to HPV Vaccination”
“Addressing the Challenges of HPV Vaccination”
"Challenging Cases in the Diagnosis and Management of Invasive Fungal Infections”
“Optimal Immunization Strategies in Adults under 65”
“Implementing IDSA and ADA Guidelines for the Management of Diabetic Foot Infection”
“New Strategies for the Diagnosis and Treatment of Clostridium difficile Infection”
“Meeting the Challenge of Fungal Infection: Risk Assessment and the Role of Antifungal Agents”
“Identification and Treatment of Community-Associated MRSA”
“Epidemiology, Diagnosis, and Treatment in the Era of Community Onset MRSA, Prevention and Management of a Recurrent Infection”
“Skin and Soft Tissue Infections in Patients with Diabetes, including Cellulitis, Ulcers, and Osteomyelitis”
“Aspergillus and Fusarium: The Epidemiology, Diagnosis, and Treatment of Medically Important Molds”
“Candida and Cryptococcus: The Epidemiology, Diagnosis, and Treatment of Medically Important Yeast”
“Community-acquired MRSA: Managing These Puzzling Bacteria”
“Understanding and Implementing Hepatitis A, Influenza, Pneumococcus, and Rotavirus Vaccination in Infants and Young Children”

John G. Bartlett,
MD

John G. Bartlett, MD

Professor
Johns Hopkins University School of Medicine
Division of Infectious Diseases

This faculty member participated in the following program(s)
“New Strategies for the Diagnosis and Treatment of Clostridium difficile Infection”
“Highlights from the 19th Conference on Retroviruses and Opportunistic Infections: CROI in Context”
“Management of the Treatment Experienced Patient with HIV Infection”
"Initiation of Antiretroviral Therapy for HIV: Insights and Rationale"
“Clinical Updates in the Management of HIV from the 49th ICAAC® Conference”
“Clinical Updates from the 5th IAS Conference on HIV Pathogenesis, Treatment, and Prevention”
“48th Annual ICAAC®/IDSA 46th Annual Meeting Highlights on HIV”

David Bell,
MD, MPH

David Bell, MD, MPH

Associate Professor
Population and Family Health and Pediatrics
Columbia Univesrity Medical Center
New York, NY

This faculty member participated in the following program(s)
“Addressing the Challenges of HPV Vaccination”

Wendy Bennett,
MD, MPH
Wendy Bennett, MD, MPH

Assistant Professor of Medicine
Division of General Internal Medicine
Johns Hopkins University School of Medicine
Baltimore, MD

This faculty member participated in the following program(s)
“Diabetes and Pregnancy: Updated Screening and Treatment Guidelines to Improve Outcomes”

Deanna Bridge Najera,
MPAS, MS, PA-C, NCC, DFAAPA, CAQ-Psych
Deanna Bridge Najera, MPAS, MS, PA-C, NCC, DFAAPA, CAQ-Psych

Department of Emergency Medicine
Carroll Hospital
Westminster, Maryland
TrueNorth Wellness Center
Hanover, Pennsylvania
Agricultural Worker Program
Gettysburg, Pennsylvania

This faculty member participated in the following program(s)
“Herpes Zoster Vaccination: What Clinicians Need to Know to Improve Vaccination Rates”

Todd T. Brown,
MD, Phd

Todd T. Brown, MD, Phd

Assistant Professor of Medicine
Division of Endocrinology and Metabolism
Johns Hopkins University School of Medicine

This faculty member participated in the following program(s)
“HIV-Associated Lipoatrophy – Management and Treatment Considerations”

Michael A. Chattergoon,
MD, PhD
Michael A. Chattergoon, MD, PhD

Fellow, Division of Infectious Diseases
Johns Hopkins University School of Medicine

This faculty member participated in the following program(s)
“Optimizing Vaccination in Immunosuppressed Patients with Autoimmune and Inflammatory Disease”
"Challenging Cases in the Diagnosis and Management of Invasive Fungal Infections”
“Highlights from the 2015 Conference on Retroviruses and Opportunistic Infections”
“Implementing IDSA and ADA Guidelines for the Management of Diabetic Foot Infection”
“Identification and Treatment of Community-Associated MRSA”
“Community-acquired MRSA: Managing These Puzzling Bacteria”

Stephen Clement,
MD
Stephen Clement, MD

Director, Endocrine Services
INOVA Fairfax Hospital
Fall Church, VA

This faculty member participated in the following program(s)
“Improving Patient Outcomes: Hypoglycemia Risk Reduction in Patients with Type 2 Diabetes Mellitus”

Joseph Cofrancesco Jr.,
MD, MPH, FACP
Joseph Cofrancesco Jr., MD, MPH, FACP

Associate Professor of Medicine
Director, Johns Hopkins Lipodystrophy and Metabolic Complications Clinic
Medical Director, HIV Services, The Rockland Physicians Group at Green Spring Station
Johns Hopkins University School of Medicine

This faculty member participated in the following program(s)
“HIV-Associated Lipoatrophy – Management and Treatment Considerations”
“Management of Intersecting Epidemics: Metabolic Disorders and Liver Disease in HIV”
“Assessing and Managing Cardiovascular Risk in Patients with HIV”

Calvin J. Cohen,
MD, MSc
Calvin J. Cohen, MD, MSc

Clinical Instructor of Medicine
Harvard Medical School
Research Director, Harvard Vanguard Medical Associates
Director of Research, Community Research Initiative of New England

This faculty member participated in the following program(s)
“HIV-Associated Lipoatrophy – Management and Treatment Considerations”
“Clinical Updates in the Management of HIV from the 49th ICAAC® Conference”
“Guidelines and Practice in Initiating Antiretroviral Therapy in 2011”

Sara E. Cosgrove,
MD, MS
Sara E. Cosgrove, MD, MS

Assistant Professor, Department of Medicine, Division of Infectious Diseases
Director, Antibiotic Management Program
Associate Hospital Epidemiologist
Johns Hopkins Medical Institutions

This faculty member participated in the following program(s)
“Epidemiology, Diagnosis, and Treatment in the Era of Community Onset MRSA, Prevention and Management of a Recurrent Infection”
“Skin and Soft Tissue Infections in Patients with Diabetes, including Cellulitis, Ulcers, and Osteomyelitis”
“48th Annual ICAAC®/IDSA 46th Annual Meeting Highlights on Antibiotics and Vaccines”

Thomas Donner,
MD, (planning committee)
Thomas Donner, MD (planning committee)

Associate Professor of Medicine
Division of Endocrinology and Metabolism
Johns Hopkins University School of Medicine

This faculty member participated in the following program(s)
“Management of Persistent Hyperglycemia in T2DM: Beyond Starting Doses of Basal Insulin” “Improving Patient Outcomes: Hypoglycemia Risk Reduction in Patients with Type 2 Diabetes Mellitus”
“Optimizing Patient Outcomes: Sequencing Therapy in Type 2 Diabetes – Part 2: Managing Persistent Hyperglycemia”

Brendan Everett,
MD, MPH
Brendan Everett, MD, MPH

Associate Professor, Harvard Medical School
Director, General Cardiology Inpatient Service, Brigham and Women’s Hospital
Division of Endocrinology Faculty
Divisions of Cardiovascular and Preventive Medicine
Boston, MA

This faculty member participated in the following program(s)
“Type 2 Diabetes and Cardiovascular Outcomes: Updates on SGLT2 Inhibitors and GLP-1 Receptor Agonists”

William A. Fisher II,
MD
William A. Fisher II, MD

Associate Professor of Medicine
Division of Pulmonary and Critical Care Medicine
Institute for Global Health and Infectious Diseases
The University of North Carolina School of Medicine
Chapel Hill, NC

This faculty member participated in the following program(s)
“Current Evidence and Controversies in COVID-19: Discussion on Best Practices Amid Changing Evidence”

Sandra Adamson Fryhofer,
MD, MACP, FRCP
Sandra Adamson Fryhofer, MD, MACP, FRCP

Adjunct Associate Professor of Medicine
Emory University School of Medicine
Atlanta, GA
Liaison Representative to Advisory Committee on Immunization Practices (AICP) of CDC from American College of Physicians

This faculty member participated in the following program(s)
“Optimal Immunization Strategies in Adults under 65”

Joel E. Gallant,
MD, MPH
Joel E. Gallant, MD, MPH

Professor of Medicine, Division of Infectious Diseases
Johns Hopkins University School of Medicine
Professor of Epidemiology, Johns Hopkins Bloomberg School of Public Health
Associate Director, Johns Hopkins AIDS Service

This faculty member participated in the following program(s)
“Management of the Treatment Experienced Patient with HIV Infection”
“Initiation of Antiretroviral Therapy for HIV: Insights and Rationale”
“Management of Intersecting Epidemics: Metabolic Disorders and Liver Disease in HIV”

Om P. Ganda,
MD
Om P. Ganda, MD

Associate Clinical Professor of Medicine
Harvard Medicine School
Chair, Clinical Oversight Committee
Joslin Diabetes Center
Boston, MA

This faculty member participated in the following program(s)
“Innovations in Prandial Glucose Control for Patients with Type 2 Diabetes Mellitus”

Amita Gupta,
MD, MHS
Amita Gupta, MD, MHS

Deputy Director of the Johns Hopkins University Center for Clinical Global Health Education
Assistant Professor of Infectious Diseases
Johns Hopkins University School of Medicine

This faculty member participated in the following program(s)
“Clinical Updates from the 5th IAS Conference on HIV Pathogenesis, Treatment, and Prevention”

Lawrence Herman,
MPA, RPA-C, DFAAPA
Lawrence Herman, MPA, RPA-C, DFAAPA

Dean and Professor
College of Health Sciences
Physician Asssistant Studies
Gardner-Webb University
Boiling Springs, NC

This faculty member participated in the following program(s)
“Addressing the Challenges of HPV Vaccination”
“Optimal Immunization Strategies in Adults under 65”
“Understanding and Implementing Hepatitis A, Influenza, Pneumococcus, and Rotavirus Vaccination in Infants and Young Children”

Charles Hicks,
MD
Charles Hicks, MD

Associate Professor of Medicine, Division of Infectious Diseases
Duke University Medical Center

This faculty member participated in the following program(s)
“Management of the Treatment Experienced Patient with HIV Infection”
“Clinical Updates from the 5th IAS Conference on HIV Pathogenesis, Treatment, and Prevention”

Christopher Hoffmann,
MD, MPH
Christopher Hoffmann, MD, MPH

Assistant Professor
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Johns Hopkins AIDS Services

This faculty member participated in the following program(s)
“Highlights from the 2015 Conference on Retroviruses and Opportunistic Infections”
“Highlights from the 2014 Conference on Retroviruses and Opportunistic Infections – Part 2”
“Highlights from the 2014 Conference on Retroviruses and Opportunistic Infections – Part 1”
“Highlights from the 19th Conference on Retroviruses and Opportunistic Infections: CROI in Context”
“Guidelines and Practice in Initiating Antiretroviral Therapy in 2011”
“Assessing and Managing Cardiovascular Risk in Patients with HIV”

Michael D. Hogue,
PharmD, FAPha, FNAP
Michael D. Hogue, PharmD, FAPhA, FNAP

Dean and Professor
Loma Linda University
School of Pharmacy
Loma Linda, California

This faculty member participated in the following program(s)
“Herpes Zoster Vaccination: What Clinicians Need to Know to Improve Vaccination Rates”

Edward H. Jasper,
MD
Edward H. Jasper, MD

Medical Director of Emergency Management
Associate Professor Emergency Medicine
Thomas Jefferson University Hospital
Philadelphia, PA

This faculty member participated in the following program(s)
“Current Evidence and Controversies in COVID-19: Discussion on Best Practices Amid Changing Evidence”

Rita Kalyani,
MD, MHS
Rita Kalyani, MD, MHS

Editor-in-Chief, Johns Hopkins Diabetes Guide
Associate Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore, MD

This faculty member participated in the following program(s)
“Type 2 Diabetes and Cardiovascular Outcomes: Updates on SGLT2 Inhibitors and GLP-1 Receptor Agonists”
“Optimizing Patient Outcomes: Sequencing Therapy in Type 2 Diabetes – Part 2: Managing Persistent Hyperglycemia”
“Optimizing Patient Outcomes: Sequencing Therapy in Type 2 Diabetes – Part 1: Lifestyle Modifications and First-Line Agents”

Rebecca A. Kazin,
MD
Rebecca A Kazin, MD

Assistant Professor of Dermatology
Johns Hopkins University School of Medicine
Medical Director of the Johns Hopkins Cosmetic Center at Greenspring Station

This faculty member participated in the following program(s)
“HIV-Associated Lipoatrophy – Management and Treatment Considerations1”

Armand Krikorian,
MD, FACE
Armand Krikorian, MD, FACE

Program Director, Internal Medicine
University of Illinois at Chicago/Advocate Christ Medical Center
Associate Professor of Clinical Medicine
University of Illinois at Chicago

This faculty member participated in the following program(s)
“Management of Persistent Hyperglycemia in T2DM: Beyond Starting Doses of Basal Insulin”

Clare J. Lee,
MD
Clare J. Lee, MD

Assistant Professor of Medicine (2/15)
Diabetes Center
Division of Endocrinology, Diabetes and Metabolism
Johns Hopkins University School of Medicine
Baltimore, MD

This faculty member participated in the following program(s)
“Innovations in Prandial Glucose Control for Patients with Type 2 Diabetes Mellitus”
“Diabetes and Pregnancy: Updated Screening and Treatment Guidelines to Improve Outcomes”

Gregory M. Lucas,
MD, PhD
Gregory M. Lucas, MD, PhD

Associate Professor of Medicine
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Johns Hopkins AIDS Services

This faculty member participated in the following program(s)
“48th Annual ICAAC®/IDSA 46th Annual Meeting Highlights on HIV”
“Guidelines and Practice in Initiating Antiretroviral Therapy in 2011”

David H. Madoff,
MD, PhD
David H. Madoff, MD, PhD

Clinical Assistant Professor of Medicine
The Johns Hopkins University School of Medicine
Director, The Woodholme Center for Diabetes and Endocrine Disorders

This faculty member participated in the following program(s)
“Improving Patient Outcomes: Hypoglycemia Risk Reduction in Patients with Type 2 Diabetes Mellitus”
“Optimizing Patient Outcomes: Sequencing Therapy in Type 2 Diabetes – Part 2: Managing Persistent Hyperglycemia”

Russell L. Margolis,
MD
Russell L. Margolis, MD

Johns Hopkins Schizophrenia Center Director
Laboratory of Genetic Neurobiology
Professor of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine
Baltimore, MD

This faculty member participated in the following program(s)
“Addressing the Constellation of Symptoms in Schizophrenia: Raising Awareness to Improve Outcomes”

Kieren A. Marr,
MD
Kieren A. Marr, MD

Professor of Medicine
Director, Transplant and Oncology Infectious Diseases Program
Johns Hopkins University School of Medicine

This faculty member participated in the following program(s)
“Aspergillus and Fusarium: The Epidemiology, Diagnosis, and Treatment of Medically Important Molds”
“Candida and Cryptococcus: The Epidemiology, Diagnosis, and Treatment of Medically Important Yeast”

Nisa M. Maruthur,
MD, MHS
Nisa M. Maruthur, MD, MHS

Assistant Professor of Medicine and Epidemiology
Division of General Internal Medicine
Associate Director, General Internal Medicine Fellowship
Core Faculty, Welch Center for Prevention, Epidemiology and Clinical Research
Johns Hopkins University

This faculty member participated in the following program(s)
“Optimizing Patient Outcomes: Sequencing Therapy in Type 2 Diabetes – Part 1: Lifestyle Modifications and First-Line Agents”

Nestoras Mathioudakis,
MD
Nestoras Mathioudakis, MD

Assistant Director, Inpatient Diabetes Management Service
Assistant Professor of Medicine
Division of Endocrinology and Metabolism
Johns Hopkins University School of Medicine

This faculty member participated in the following program(s)
“Optimizing Patient Outcomes: Sequencing Therapy in Type 2 Diabetes – Part 1: Lifestyle Modifications and First-Line Agents”

Michael Melia,
MD
Michael Melia, MD

Instructor, Department of Medicine
The Johns Hopkins Hospital

This faculty member participated in the following program(s)
“Clinical Updates in the Management of HIV from the 49th ICAAC® Conference”
“48th Annual ICAAC®/IDSA 46th Annual Meeting Highlights on HIV”
“48th Annual ICAAC®/IDSA 46th Annual Meeting Highlights on Antibiotics and Vaccines”

Dionissios Neofytos,
MD, MPH
Dionissios Neofytos, MD, MPH

Assistant Professor of Medicine
Transplant and Oncology Infectious Diseases Program
Johns Hopkins University School of Medicine

This faculty member participated in the following program(s)
“Aspergillus and Fusarium: The Epidemiology, Diagnosis, and Treatment of Medically Important Molds”
“Candida and Cryptococcus: The Epidemiology, Diagnosis, and Treatment of Medically Important Yeast”

Eric Nuermberger,
MD
Eric Nuermberger, MD

Assistant Professor of Medicine and International Health
Johns Hopkins University School of Medicine

This faculty member participated in the following program(s)
“Skin and Soft Tissue Infections in Patients with Diabetes, including Cellulitis, Ulcers, and Osteomyelitis

Kathleen R. Page,
MD
Kathleen R. Page, MD

Assistant Professor of Medicine
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Johns Hopkins AIDS Services

This faculty member participated in the following program(s)
“Guidelines and Practice in Initiating Antiretroviral Therapy in 2011

Godfrey Pearlson,
MA, MBBS
Godfrey Pearlson, MA, MBBS

Professor of Psychiatry and Neuroscience
Yale University
Founding Director of the Olin Neuropsychiatry Research Center
Institute of Living
New Haven, CT

This faculty member participated in the following program(s)
“Multidisciplinary Care in Schizophrenia: Exploring Models, Addressing Barriers and Providing Optimal Treatment”

Trish M. Perl,
MD, MSc
Trish M. Perl, MD, MSc

Professor of Medicine
Division of Infectious Diseases and Hospital Epidemiology and Infection Prevention
Johns Hopkins University School of Medicine

This faculty member participated in the following program(s)
“New Strategies for the Diagnosis and Treatment of Clostridium difficile Infection”

Paul A. Pham,
PharmD
Paul A. Pham, PharmD

Clinical Pharmacist
Research Associate
Johns Hopkins University School of Medicine
Division of Infectious Disease

This faculty member participated in the following program(s)
“Meeting the Challenge of Fungal Infection: Risk Assessment and the Role of Antifungal Agents”

Philip Raskin,
MD, FACP, FACE, CDE
Philip Raskin, MD, FACP, FACE, CDE

Professor of Medicine
Clifton and Betsy Robinson Chair in Biomedical Research
University of Texas Southwestern Medical Center
Dallas, TX

This faculty member participated in the following program(s)
“Innovations in Prandial Glucose Control for Patients with Type 2 Diabetes Mellitus”
“Diabetes and Pregnancy: Updated Screening and Treatment Guidelines to Improve Outcomes”

Richard E. Rothman,
MD, PhD, FACEP
Richard E. Rothman , MD, PhD, FACEP

Associate Professor of Emergency Medicine
Joint Appointment, Medicine Division of Infectious Diseases
Director of Research Department of Emergency Medicine
Johns Hopkins University School of Medicine

This faculty member participated in the following program(s)
“Epidemiology, Diagnosis, and Treatment in the Era of Community Onset MRSA, Prevention and Management of a Recurrent Infection”

Catherine Salva,
MD
Catherine Salva, MD

Director, Residency Program
Hospital of the University of Pennsylvania
Medical Director
Helen O. Dickens Center for Women's Health
Associate Professor
Clinical Obstetrics and Gynecology
University of Pennsylvania
Philadelphia, PA

This faculty member participated in the following program(s)
“Confronting Barriers to HPV Vaccination”

Paul E. Sax,
MD
Paul E. Sax, MD

Clinical Director, HIV Program and Division of Infectious DiseasesBrigham and Women’s Hospital
Associate Professor of Medicine
Harvard Medical School

This faculty member participated in the following program(s)
“Highlights from the 2014 Conference on Retroviruses and Opportunistic Infections – Part 2”
“Highlights from the 2014 Conference on Retroviruses and Opportunistic Infections – Part 1”
“Initiation of Antiretroviral Therapy for HIV: Insights and Rationale”

Margot L. Savoy,
MD, MPH, FAAFP, FABC, CPE, CMQ
Margot L. Savoy, MD, MPH, FAAFP, FABC, CPE, CMQ

Director, Christina Care Health System
Family & Community Medicine
Wilmington, DE
Clinical Assistant Professor
Sidney Kimmel Medical College
Jefferson University
Philadelphia, PA

This faculty member participated in the following program(s)
“Confronting Barriers to HPV Vaccination”

Mansur Shomali,
MD
Mansur Shomali, MD

Adjunct Associate Professor of Medicine
University of Maryland School of Medicine
Division of Endocrinology Faculty
MedStar Union Memorial Hospital
Chief Medical Officer, Welldoc, Inc.
Baltimore, MD

This faculty member participated in the following program(s)
“Type 2 Diabetes and Cardiovascular Outcomes: Updates on SGLT2 Inhibitors and GLP-1 Receptor Agonists”

Jay Shubrook,
DO, FACOFP, FAAFP
Jay Shubrook, DO, FACOFP, FAAFP

Professor, Primary Care Department
Director of Clinical Research and Diabetes Services
Touro University California College of Osteopathic Medicine
Vallejo, CA

This faculty member participated in the following program(s)
“Basal Insulin and Beyond: Management of Persistent Hyperglycemia in T2DM”

Aniket R. Sidhaye,
MD
Aniket R. Sidhaye, MD

Assistant Professor of Medicine and Pediatrics
Division of Endocrinology, Diabetes and Metabolism
Johns Hopkins University School of Medicine
Baltimore, MD

This faculty member participated in the following program(s)
“Basal Insulin and Beyond: Management of Persistent Hyperglycemia in T2DM”
“Management of Persistent Hyperglycemia in T2DM: Beyond Starting Doses of Basal Insulin”

Aniket R. Sidhaye,
MD
Benjamin J Smith, DMSc, PA-C, DFAAPA

Director of Didactic Education, Assistant Professor
School of Physician Assistant Practice
Florida State University College of Medicine
Tallahassee, Florida

This faculty member participated in the following program(s)
“Optimizing Vaccination in Immunosuppressed Patients with Autoimmune and Inflammatory Disease”

Mark S. Sulkowski,
MD

Glenn Treisman,
MD, PhD
Glenn Treisman, MD, PhD

Eugene Meyer III Professor of Psychiatry Care and Internal Medicine
Director, AIDS Psychiatry Service
Johns Hopkins University School of Medicine
Baltimore, MD

This faculty member participated in the following program(s)
“Addressing the Constellation of Symptoms in Schizophrenia: Raising Awareness to Improve Outcomes”
“Multidisciplinary Care in Schizophrenia: Exploring Models, Addressing Barriers and Providing Optimal Treatment”

Aimee K. Zaas,
MD, MHS
Aimee K. Zaas, MD, MHS

Associate Professor of Medicine
Department of Medicine
Duke University Medical Center
Division of Infectious Diseases and International Health

This faculty member participated in the following program(s)
“Meeting the Challenge of Fungal Infection: Risk Assessment and the Role of Antifungal Agents”

Farhad Zangeneh,
MD, FACP, FACE
Farhad Zangeneh, MD, FACP, FACE

Assistant Clinical Professor of Medicine
George Washington University School of Medicine
Consultant in Endocrinology/Medical Director
Endocrine, Diabetes & Osteoporosis Clinic (EDOC)
Sterling, VA

This faculty member participated in the following program(s)
“Basal Insulin and Beyond: Management of Persistent Hyperglycemia in T2DM”

Title: "COVID-19 Impact: Diagnostics, Viral Lifecycle, Long-Term Sequalae, and Therapeutic Interventions”

Presented by: Johns Hopkins School of Medicine and American Academy of Physician-Associates (AAPA)

Release Date: November 30, 2021
Expiration Date: November 30, 2022

Estimated time to complete this activity: 30 minutes per module. Each of the 3 module activities have been approved for a maximum of 0.50AMA PRA Category 1 Credit™.

Acknowledgement of Commercial Support: Supported by an independent educational grant from Pfizer

There are no activities currently available for this guide.